Acute Promyelocytic Leukemia-like AML: Genetic Perspective and Clinical Implications
Author Information
Author(s): Guarnera Luca, Fabiani Emiliano, Falconi Giulia, Silvestrini Giorgia, Catanoso Maria Luigia, Divona Mariadomenica, Voso Maria Teresa
Primary Institution: University of Rome Tor Vergata
Hypothesis
This review aims to describe APL-like entities reported to-date and discuss their biological background and clinical implications.
Conclusion
APL-like AMLs present significant heterogeneity in terms of genetic lesions, clinical presentation, sensitivity to treatments, and prognosis.
Supporting Evidence
- APL accounts for 8-15% of acute myeloid leukemia cases.
- Over 40 APL-like entities have been reported.
- Diagnosis of APL-like AML is challenging due to their heterogeneity.
Takeaway
Some types of leukemia look like a rare form called APL but don't have the same genetic changes, making them harder to diagnose and treat.
Methodology
This review summarizes literature reports and studies addressing APL-like entities, investigates biological mechanisms of leukemogenesis, evaluates clinical characteristics, and discusses future research directions.
Limitations
The review may not cover all APL-like entities due to the evolving nature of research in this area.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website